// App-Quantinova.ai

: Characteristics of new users of single and multiple-inhaler triple therapy for COPD in primary care in England

Researchers

Presenter

  • Kieran Rothnie

Principal Investigators

  • Sandra Joksaite

  • Afisi Ismaila

  • Leah Sansbury

Medical Centers

  • Value Evidence and Outcomes, R&D Global Medical, GlaxoSmithKline plc., London, United Kingdom

  • Value Evidence and Outcomes, R&D Global Medical, GlaxoSmithKline plc., Collegeville, United States of America

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A